EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Kangfuxin liquid enema plus adalimumab for ulcerative colitis: a retrospective cohort study

Meimei Zhao, Tao Yu

American Journal of Translational Research · 2026 · 18 (5) · 4536-4546

DOI: 10.62347/qhvy7929 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Meimei Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spleen-Stomach Diseases I, Shaanxi Provincial Hospital of Traditional Chinese Medicine Xi'an 710003, Shaanxi, China. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Kangfuxin liquidadalimumabcombination therapyulcerative colitis

Autor:innen und Institutionen

  • Department of Spleen-Stomach Diseases I, Shaanxi Provincial Hospital of Traditional Chinese Medicine Xi'an 710003, Shaanxi, China.

Zitieren

APA

Zhao, M., & Yu, T. (2026). Kangfuxin liquid enema plus adalimumab for ulcerative colitis: a retrospective cohort study. American Journal of Translational Research, 18(5), 4536-4546. https://doi.org/10.62347/qhvy7929

Vancouver

Zhao M, Yu T. Kangfuxin liquid enema plus adalimumab for ulcerative colitis: a retrospective cohort study. American Journal of Translational Research. 2026;18(5):4536-4546. doi:10.62347/qhvy7929

BibTeX
@article{Zhao2026,
  author = {Zhao, Meimei and Yu, Tao},
  title = {Kangfuxin liquid enema plus adalimumab for ulcerative colitis: a retrospective cohort study},
  journal = {American Journal of Translational Research},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {4536--4546},
  doi = {10.62347/qhvy7929}
}
Kostenlos starten →